Pharma Journalist - Page 62 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, NJ Site

OMass Therapeutics Partners with Genentech to Develop Inflammatory Bowel Disease Therapies

FDA Approves Henlius and Organon’s BILDYOS and BILPREVDA Biosimilars to PROLIA and XGEVA

Boehringer’s HERNEXEOS Approved in China as First Oral Targeted Therapy for HER2-Mutant Advanced NSCLC

FDA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Maintenance Therapy

Santhera Partners with Ikris Pharma Network to Distribute AGAMREE in India

Sanofi’s Wayrilz Approved in US as First BTK Inhibitor for Immune Thrombocytopenia

Novartis’ Leqvio Achieves Early LDL-C Goals with Less Muscle Pain

Heidelberg Pharma Partner Telix Pharmaceuticals Provides Regulatory Update on Imaging Agent TLX250-CDx

Sandoz Launches Rivaroxaban in Germany, Broadening Access to Antithrombotic Care